Clinical trial examines use of valve for treating severe emphysema
Researchers at UC are conducting the local arm of a clinical trial that could provide less invasive, effective treatment for patients with severe emphysema.
Sadia Benzaquen, MD, assistant professor in the division of pulmonary, critical care and sleep medicine and a UC Health director of interventional pulmonology, is leading the trial-called EMPROVE-which will specifically evaluate the safety and efficacy of endobronchial valves for patients with severe emphysema. Currently, these patients are treated with lung transplant or volume reduction surgery which removes part of the poorly functioning areas of the lung space occupying tissue from each lung.
For patients that cannot undergo transplant for lung reduction surgery, there are currently no effective treatment options; this trial could change the standard of care for patients with severe emphysema complications. Read more.